{
    "2020-07-09": [
        [
            {
                "time": "2023-10-18",
                "original_text": "FDA Approves Expanded BOTOXÂ® (onabotulinumtoxinA) Label for the Treatment of Pediatric Patients with Spasticity",
                "features": {
                    "keywords": [
                        "FDA",
                        "BOTOX",
                        "Expanded Label",
                        "Pediatric Patients",
                        "Spasticity"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "n/a"
                }
            }
        ]
    ]
}